Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Diminished anticoagulant effects of warfarin with concomitant mercaptopurine therapy.

Martin LA, Mehta SD.

Pharmacotherapy. 2003 Feb;23(2):260-4.

PMID:
12587816
2.
3.
4.

Difficulties in anticoagulation management during coadministration of warfarin and rifampin.

Lee CR, Thrasher KA.

Pharmacotherapy. 2001 Oct;21(10):1240-6.

PMID:
11601670
5.

A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.

Aki Z, Kotiloğlu G, Ozyilkan O.

Am J Gastroenterol. 2000 Apr;95(4):1093-4. No abstract available.

PMID:
10763974
6.

Timing of expression of blood coagulation abnormality in patients treated with warfarin and s-1 concomitantly.

Yamada T, Watanabe H, Yano T, Nonaka T, Takada A, Sonoda M, Kubota T, Egashira N, Oishi R.

Yakugaku Zasshi. 2010 Jul;130(7):955-60.

7.

A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.

Shah HR, Ledbetter L, Diasio R, Saif MW.

Clin Colorectal Cancer. 2006 Jan;5(5):354-8.

PMID:
16512995
8.
9.

Mercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia.

Neokleous N, Seimeni O, Koumas S, Prokopiou C.

Leuk Lymphoma. 2012 Mar;53(3):495-6. doi: 10.3109/10428194.2011.619609. Epub 2011 Oct 24. No abstract available.

PMID:
21902579
10.
11.

Identification of a gemcitabine-warfarin interaction.

Kinikar SA, Kolesar JM.

Pharmacotherapy. 1999 Nov;19(11):1331-3.

PMID:
10555940
12.

Interaction between warfarin and nafcillin: case report and review of the literature.

Kim KY, Frey RJ, Epplen K, Foruhari F.

Pharmacotherapy. 2007 Oct;27(10):1467-70. Review.

PMID:
17896903
13.

Potential interaction between warfarin and high dietary protein intake.

Hornsby LB, Hester EK, Donaldson AR.

Pharmacotherapy. 2008 Apr;28(4):536-9. doi: 10.1592/phco.28.4.536.

PMID:
18363537
14.

An adverse interaction between warfarin and capecitabine: a case report and review of the literature.

Copur MS, Ledakis P, Bolton M, Morse AK, Werner T, Norvell M, Muhvic J, Chu E.

Clin Colorectal Cancer. 2001 Nov;1(3):182-4. Review.

PMID:
12450435
15.

Interactions between warfarin and three commonly prescribed fluoroquinolones.

Carroll DN, Carroll DG.

Ann Pharmacother. 2008 May;42(5):680-5. doi: 10.1345/aph.1K605. Epub 2008 Apr 15. Review.

PMID:
18413687
16.

Probable interaction between tolterodine and warfarin.

Taylor JR.

Pharmacotherapy. 2006 May;26(5):719-21.

PMID:
16718947
17.

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

Pharmacotherapy. 2007 May;27(5):691-6.

PMID:
17461704
18.

[Interaction between warfarin and nalidic acid].

Gulløv AL, Koefoed BG, Petersen P.

Ugeskr Laeger. 1996 Sep 9;158(37):5174-5. Danish.

PMID:
8848852
19.

Retrospective assessment of potential interaction between levofloxacin and warfarin.

Mercadal Orfila G, Gracia García B, Leiva Badosa E, Perayre Badía M, Reynaldo Martínez C, Jodar Masanés R.

Pharm World Sci. 2009 Apr;31(2):224-9. doi: 10.1007/s11096-008-9265-9. Epub 2008 Dec 6.

PMID:
19067226
20.

[Difficult management of warfarin anticoagulant therapy due to S-1 administration for gastric cancer--report of a case].

Marutaka M, Kubota Y, Yoshida R, Orita Y.

Gan To Kagaku Ryoho. 2009 Sep;36(9):1561-3. Japanese.

PMID:
19755834

Supplemental Content

Support Center